PT  - JOURNAL ARTICLE
AU  - Judith Pannier
AU  - Norbert Nass
AU  - Gerhard Behre
TI  - Monoclonal antibodies therapy for Covid-19 - Experiences at a regional hospital
AID  - 10.1101/2021.09.22.21263488
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.22.21263488
4099  - http://medrxiv.org/content/early/2021/09/23/2021.09.22.21263488.short
4100  - http://medrxiv.org/content/early/2021/09/23/2021.09.22.21263488.full
AB  - Applying monoclonal antibodies against Covid-19 is a promising treatment option for avoiding severe outcomes. However, real life data, especially in regional hospitals are still scarce. We here report on our first results with this therapy in a retrospective, observational study. Indeed, compared to a risk-factor matched reference group, hospitalisation time was reduced but survival rate and kinetics of SARS-CoV-2 RT-PCR results remained apparently unaffected.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by institutional funds only. The monoclonal antibodies were provided by the German Federal Ministry of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethikkommission Otto von Guericke University MagdeburgAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll necessary data are included in the manuscript. Further details will be made available on reasonable request